Investment Focus

Headquarters

US

Check Size

$0.5M – $10.0M

Investment Focus

Life Sciences Tools, Diagnostics, Therapeutics, Digital Health, Sustainability, Single cell analysis, Spatial biology, Multi-omic profiling, Synthetic biology, Molecular characterization, Infectious disease diagnostics, Cell free DNA, RNA and protein analysis, Pediatric genomics, Point of care solutions, Cell and gene therapies, Gene editing platforms, AI-enabled drug discovery, Nonviral delivery systems, Therapeutic protein libraries, Virtual care delivery, Patient engagement and care navigation, AI/ML enabled clinical care innovation, Agricultural biotechnology, Biomanufacturing, Bioremediation, Bioexploration

Investment Thesis

Illumina Ventures is a venture capital firm focused on investing in early-stage companies in the genomics and precision health sectors. They aim to build an ecosystem and translate investment into innovation, accelerating the impact on human health. The firm leverages its domain expertise, operating experience, and strategic relationship with Illumina (NASDAQ: ILMN) to identify and build companies that will transform healthcare. Illumina Ventures operates as true partners to entrepreneurs, supporting the development of breakthrough science and technology into market-leading companies. Through Illumina Ventures Labs, they accelerate value creation for early-stage genomics start-ups by providing access to capital, sequencing, mentorship, and fully equipped genomics lab capabilities.

Deal Pipeline

Track your relationship with Illumina Ventures and manage next steps in your fundraising CRM.


Get Matched with VCs

Use GRID's AI-powered VC matcher to find investors that are the best fit for your startup based on sector, stage, geography, and more.

Get AI-Powered Matching Back to Directory

Team at Illumina Ventures

20 professionals